Surveys / Trackers / ATUs

The precision medicine market is dynamic, and technological and clinical disruption can cause it to pivot on a dime. Track your markets closely, distinguish signal from noise, and respond accordingly.

Our Experts

Pranay Madan

Andrew Aijian

Steve Beuchaw

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

View

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

View

Voice-of-Customer Research

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

View

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Clinical Diagnostics

Infectious Pathogen Diagnostics Technology Commercialization

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

View

Voice-of-Customer Research

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch